<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Sergei Polevikov on Medium]]></title>
        <description><![CDATA[Stories by Sergei Polevikov on Medium]]></description>
        <link>https://medium.com/@AIHealthUncut?source=rss-e2ea40a603da------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*1CaVYwsCMSKL3GP9eMnS8Q.png</url>
            <title>Stories by Sergei Polevikov on Medium</title>
            <link>https://medium.com/@AIHealthUncut?source=rss-e2ea40a603da------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sun, 22 Nov 2026 19:20:48 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@AIHealthUncut/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[I’d Short Anthropic’s IPO. My Co-Host Would Buy It All Day.]]></title>
            <link>https://medium.com/@AIHealthUncut/id-short-anthropic-s-ipo-my-co-host-would-buy-it-all-day-94072cb0ed70?source=rss-e2ea40a603da------2</link>
            <guid isPermaLink="false">https://medium.com/p/94072cb0ed70</guid>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[walmart]]></category>
            <category><![CDATA[openevidence]]></category>
            <category><![CDATA[anthropic-ai]]></category>
            <dc:creator><![CDATA[Sergei Polevikov]]></dc:creator>
            <pubDate>Wed, 11 Nov 2026 16:11:46 GMT</pubDate>
            <atom:updated>2026-11-11T16:11:46.150Z</atom:updated>
            <content:encoded><![CDATA[<h3>Plus: OpenEvidence’s $15B ask vs. my ~$500M, Walmart’s 9th try at healthcare, and $140B of VC money nobody can show a return on. Our October Digital Health Vitals recap.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*rSVeQ-Jdp2LEbVD6rcIW9Q.png" /></figure><p><strong><em>Welcome to AI Health Uncut, a brutally honest newsletter on AI, innovation, and the state of the healthcare market. If you’d like to sign up to receive issues over email, you can do so </em></strong><a href="https://www.fixhealth.ai/subscribe"><strong><em>here</em></strong></a><strong><em>.</em></strong></p><p><strong>I<em>mportant Disclosure.</em></strong><em> I am an independent journalist with no financial interest, long or short, in any company mentioned here, including Anthropic, OpenAI, Amazon, OpenEvidence, Doximity, Wolters Kluwer, Rock Health, Epic Systems, Abridge, Walmart, General Medicine, Eli Lilly, Teladoc Health, Clarivate, Pathos AI, Suki, Oxbridge Health, and other. Opinions are my own. Not investment advice.</em></p><p>On Oct 28, <a href="https://www.linkedin.com/in/alex-koshykov/">Alex Koshykov</a>, <a href="https://www.linkedin.com/in/stephjdavis/">Stephanie Davis</a> and I recorded the October <a href="https://www.youtube.com/@DigitalHealthInsideOut">Digital Health Vitals</a> with special guest <a href="https://www.linkedin.com/in/malak-atut/">Malak Atut</a>, a healthcare and AI founder, investor and advisor who teaches at Wharton. Everyone in this episode was looking for an exit. VCs still have no IPO window. <a href="https://www.fixhealth.ai/p/inside-openevidence-the-art-of-selling">OpenEvidence wants a buyer</a>. <a href="https://www.fixhealth.ai/p/walmart-has-failed-at-healthcare">Walmart wants to be the store</a>. And Anthropic goes to the public markets as soon as next week, which is how Stephanie and I ended up with a bet we settle in 10 years. 😉</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FnMMU8MLr7DU%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DnMMU8MLr7DU&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FnMMU8MLr7DU%2Fhqdefault.jpg&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/c447f8a5333f38595a9e39d5bd245c2d/href">https://medium.com/media/c447f8a5333f38595a9e39d5bd245c2d/href</a></iframe><p>On a personal note, I’m all for heated, fierce debates. But I don’t appreciate personal attacks, and in my opinion, this discussion went too far. But don’t take my word for it. <a href="https://www.youtube.com/watch?v=nMMU8MLr7DU">Watch the video and judge for yourself.</a></p><p><a href="https://www.youtube.com/@DigitalHealthInsideOut">Watch the episode on YouTube</a> or <a href="https://podcasts.apple.com/us/podcast/12-digital-health-vitals-openevidence-for-sale-walmart/id1876520441?i=1000799495894">listen on Apple Podcasts</a>. And here is <a href="https://www.fixhealth.ai/p/who-owns-the-doctor-in-2031-epic">September’s recap</a>.</p><p>I’ll be at <a href="https://hlth.com/events/usa">HLTH USA 2026</a> in Las Vegas next week, Nov 15 to 18, recording with Alex from the floor. Join me: <a href="https://app.ingo.me/q/56jqv">https://app.ingo.me/q/56jqv</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*3SjeohigJL6iB0i9.jpeg" /></figure><p><em>A word about how this work gets paid for. Independent investigative journalism comes at a significant cost, both in time and legal risk. That’s why I have launched the </em><a href="https://www.fixhealth.ai/sponsor"><em>AI Health Uncut Sponsorship Program</em></a><em>. AI Health Uncut’s subscribers include prominent leaders in healthcare, technology and investment, including household names you would undoubtedly recognize. Sponsorship puts your work in front of all these people, who help shape the industry’s direction, its funding and its adoption of new technologies. Sponsorship does not buy favorable editorial coverage. But I welcome like-minded sponsors who respect my editorial independence and don’t interfere with what I write.</em></p><p><a href="https://fixhealth.ai/sponsor"><strong>Become a Sponsor of AI Health Uncut</strong></a></p><p><em>I also encourage my readers to become </em><a href="https://www.fixhealth.ai/subscribe?tier=founding"><em>Founding Members</em></a><em>. I need your support. By joining, you’re not only supporting my continued investigations and research into healthcare AI. You’re also helping me make this work accessible to people who may not be able to afford a subscription, whether they’re students, between jobs, or simply going through a difficult financial period. (If that’s you, please reach out.) Thanks to the generosity of Founding Members, I’m able to provide access to anyone who needs it. Your support is what keeps the lights on.</em></p><p><a href="https://www.fixhealth.ai/subscribe?tier=founding"><strong>Become a Founding Member</strong></a></p><h3>Here is what’s inside:</h3><blockquote><strong><em>1. Rock Health Q3: Bigger Checks, Fewer Winners, No Exits</em></strong></blockquote><blockquote><strong><em>2. “That’s Self-Selection Bias, Sergei”: VC vs. Bootstrapped</em></strong></blockquote><blockquote><strong><em>3. OpenEvidence: $15B Ask, ~$500M Reality</em></strong></blockquote><blockquote><strong><em>4. Doximity + UpToDate: Is Human-in-the-Loop a Marketing Gimmick?</em></strong></blockquote><blockquote><strong><em>5. Walmart’s 9th Try: Be the Store, Not the Doctor</em></strong></blockquote><blockquote><strong><em>6. Anthropic’s S-1: Cure Cancer, or Kill Us All</em></strong></blockquote><blockquote><strong><em>7. Anthropic is Breakeven, Before the $895B Bill Arrives</em></strong></blockquote><blockquote><strong><em>8. I’d Short Anthropic. Stephanie Would Buy It All Day.</em></strong></blockquote><blockquote><strong><em>9. Bonus: The Thumbs We Ran Out of Time For</em></strong></blockquote><p><strong>➡️ …continue reading on </strong><a href="https://www.fixhealth.ai/p/id-short-anthropics-ipo-my-co-host"><strong>FixHealth.ai</strong></a></p><p>👉👉👉👉👉 Hi! My name is Sergei Polevikov. I’m an AI researcher and a healthcare AI startup founder. I combine my knowledge of AI models with my unique skills in analyzing the financial health of digital health companies, no pun intended. 😊 I never sugarcoat or filter the hard truth. Subscribe to my newsletter at <a href="https://fixhealth.ai/">FixHealth.ai</a>, follow me, support my work and join a vibrant community of healthcare AI enthusiasts! Your engagement matters. 🙏🙏🙏🙏🙏</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=94072cb0ed70" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Walmart Has Failed at Healthcare 8 Times. Now It’s Trying for a 9th.]]></title>
            <link>https://medium.com/@AIHealthUncut/walmart-has-failed-at-healthcare-8-times-now-its-trying-for-a-9th-073926fb0fcb?source=rss-e2ea40a603da------2</link>
            <guid isPermaLink="false">https://medium.com/p/073926fb0fcb</guid>
            <category><![CDATA[walmart]]></category>
            <category><![CDATA[general-medicine]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[pillpack]]></category>
            <category><![CDATA[corporate-governance]]></category>
            <dc:creator><![CDATA[Sergei Polevikov]]></dc:creator>
            <pubDate>Thu, 29 Oct 2026 15:50:45 GMT</pubDate>
            <atom:updated>2026-10-29T15:50:45.618Z</atom:updated>
            <content:encoded><![CDATA[<h3>After 20 years of clinics that closed and deals that died, Walmart is back with a healthcare marketplace run by PillPack’s founder. Is it price transparency or a new paid gatekeeper?</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*k7V4t1Vl7dPFwdxqO0gEcQ.png" /><figcaption><em>Note: This cover image was generated with Claude and does not depict an actual store.</em></figcaption></figure><p><strong><em>Welcome to AI Health Uncut, a brutally honest newsletter on AI, innovation, and the state of the healthcare market. If you’d like to sign up to receive issues over email, you can do so </em></strong><a href="https://www.fixhealth.ai/subscribe"><strong><em>here</em></strong></a><strong><em>.</em></strong></p><p><strong><em>Important Disclosure.</em></strong><em> I am an independent journalist with no financial interest, long or short, in any company mentioned here, including Walmart, Aaptiv, Aetna, Amazon (including PillPack and One Medical), Amwell, Andreessen Horowitz, Anthropic, Babylon Health, Berry Street, BetterHelp, Blueberry Pediatrics, Cabana, CheckUps, ChenMed, Cigna, Clover Health, Curai Health, Cost Plus Drug Company, CVS Health, Doximity, Eli Lilly, Elevance Health (Anthem), Epic Systems, General Medicine, GoodRx, Health at Scale, Hella+Health, Humana, Included Health (Doctor On Demand), JPMorgan Chase (Morgan Health), MeMD, Mercy, Molina Healthcare, Oak Street Health, Ochsner Health, QuadMed, Rock Health, Solace Health, Solv, Teladoc Health, Twin Health, UnitedHealth Group, VillageMD, Wheel and Zocdoc. Facts come from public records, company statements and press coverage, hyperlinked at the point of reference. Accounts attributed to people familiar with the company come from sources who spoke on condition of anonymity, and were verified against public records where possible. This article is my opinion, based on the sources cited, and is not investment, legal or medical advice.</em></p><p>While the world was mesmerized by Anthropic’s <a href="https://www.sec.gov/Archives/edgar/data/2130357/000162828026067168/anthropicpbc-sx1.htm">IPO filing</a> on Monday (apparently everyone who has ever used the Claude chatbot is now an expert on S-1 forms 😉), we all missed the big news of Walmart’s 9th attempt at healthcare. The same day, Walmart <a href="https://corporate.walmart.com/news/2026/10/better-care-services-expansion">expanded Better Care Services</a>, its online healthcare hub, into a full “healthcare store” powered by General Medicine, a startup run by PillPack co-founder TJ Parker. Shoppers can compare insured and cash prices on more than 900 products and services, from telehealth and labs to select in-person visits, drawn from General Medicine’s catalog of 2,900+. It comes 2.5 years after Walmart <a href="https://corporate.walmart.com/news/2024/04/30/walmart-health-is-closing">closed all 51 Walmart Health centers</a> and its virtual care business.</p><blockquote><strong><em>Walmart has decided that being the doctor doesn’t pay. But owning the aisle where you shop for one might.</em></strong></blockquote><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2Fr1WWB7GKyG8%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fshorts%2Fr1WWB7GKyG8&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2Fr1WWB7GKyG8%2Fhq2.jpg&amp;type=text%2Fhtml&amp;schema=youtube" width="640" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/ba991cba5c8fc26a025d542562399220/href">https://medium.com/media/ba991cba5c8fc26a025d542562399220/href</a></iframe><p><em>But first, I’m excited to be attending </em><a href="https://hlth.com/events/usa"><em>HLTH USA 2026</em></a><em>, the marquee healthcare innovation event, November 15–18 in Las Vegas! Join me: </em><a href="https://app.ingo.me/q/56jqv"><em>https://app.ingo.me/q/56jqv</em></a></p><p><em>🎙️ So… Calling all medical professionals, healthtech folks, and fans of our podcast, </em><a href="https://www.youtube.com/@DigitalHealthInsideOut"><em>Digital Health Inside Out</em></a><em>. </em><a href="https://www.linkedin.com/in/alex-koshykov/"><em>Alex Koshykov</em></a><em> and I are looking for a few brave souls willing to join us for in-person conversations that may range from serious healthcare debates to completely inappropriate healthtech dad jokes. 😄 We’ll be recording right from the floor of </em><a href="https://hlth.com/events/usa"><em>HLTH in Las Vegas</em></a><em>, November 15–18. 🎰🔥 If you’ll be there and think you’d be a good sport, drop a comment or send either of us a DM. One thing we can promise. It won’t be boring. And yes, things may get a little heated from time to time. 😉</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*jJFmILASpMvGVwhL.jpeg" /></figure><p><em>A word about how this work gets paid for. Independent investigative journalism comes at a significant cost, both in time and legal risk. That’s why I have launched the </em><a href="https://www.fixhealth.ai/sponsor"><em>AI Health Uncut Sponsorship Program</em></a><em>. AI Health Uncut’s subscribers include prominent leaders in healthcare, technology and investment, including household names you would undoubtedly recognize. Sponsorship puts your work in front of all these people, who help shape the industry’s direction, its funding and its adoption of new technologies. Sponsorship does not buy favorable editorial coverage. But I welcome like-minded sponsors who respect my editorial independence and don’t interfere with what I write.</em></p><p><a href="https://fixhealth.ai/sponsor"><strong>Become a Sponsor of AI Health Uncut</strong></a></p><p><em>I also encourage my readers to become </em><a href="https://www.fixhealth.ai/subscribe?tier=founding"><em>Founding Members</em></a><em>. I need your support. By joining, you’re not only supporting my continued investigations and research into healthcare AI. You’re also helping me make this work accessible to people who may not be able to afford a subscription, whether they’re students, between jobs, or simply going through a difficult financial period. (If that’s you, please reach out.) Thanks to the generosity of Founding Members, I’m able to provide access to anyone who needs it. Your support is what keeps the lights on.</em></p><p><a href="https://www.fixhealth.ai/subscribe?tier=founding"><strong>Become a Founding Member</strong></a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/0*AHY4XatD0fl2m5BH.png" /><figcaption>Source: <a href="https://corporate.walmart.com/news/2019/09/13/in-dallas-georgia-walmart-unveils-enhanced-store-experience-and-first-ever-walmart-health-center.">https://corporate.walmart.com/news/2019/09/13/in-dallas-georgia-walmart-unveils-enhanced-store-experience-and-first-ever-walmart-health-center.</a></figcaption></figure><p>OK, back to Walmart… Below, I go back through all 8 failures over the past 20 years, drawing on my <a href="https://www.fixhealth.ai/p/the-death-of-walmart-health-an-inside">2024 inside scoop on the death of Walmart Health</a>. And <strong>I name the names</strong> of the people who contributed to the failure of Walmart Health, along with what they promised in public while it was falling apart.</p><p>I don’t name names to be vicious, and I don’t enjoy making enemies. I name names because we, as an industry, need to learn from our mistakes, especially the big-name ones. And almost no one is paying attention to figuring out what exactly happened.</p><blockquote><strong>A note on how this works.</strong> Most of my investigations start with a tip from someone like you. I verify it with other witnesses, then add my own “mosaic theory” research on top. Everything stays confidential, always. I have been doing this for 3 years. What follows is a standing public service announcement that I run in every investigation. It is not directed at any company discussed in this piece, and nothing in this article alleges that Walmart or any of its employees or representatives has broken the law or engaged in unethical conduct.</blockquote><blockquote>If you see something unethical, or even just weird, anywhere in healthtech, do not stay silent. Tell a newspaper, tell me (DMs, Signal, WhatsApp, whatever you prefer), or, if you believe a law has been broken, tell a law enforcement agency (<a href="https://tips.fbi.gov/">tips.fbi.gov</a>).</blockquote><h3>Here is what’s inside:</h3><p><strong>1. 8 Attempts in 20 Years. All Failed.</strong></p><p><strong>2. MeMD: A Joke of a Technology, Bought With Zero Due Diligence</strong></p><p><strong>3. Walmart Health Was a Panic Response to CVS-Aetna</strong></p><p><strong>4. Slovenski, Pegus, Carmouche, Setzer: The Leadership Carousel</strong></p><p><strong>5. Medicare Advantage Was Meant to Save Walmart Health. Instead, It Killed It.</strong></p><p><strong>6. Walmart Lied and Kept a Straight Face Until the Very End</strong></p><p><strong>7. What Survived: Pharmacy, Vision, Dental and Doctor On Demand</strong></p><p><strong>8. The New Plan: Be the Store, Not the Doctor</strong></p><p><strong>9. Price Transparency or a Paid Gatekeeper?</strong></p><p><strong>10. How to Avoid Failure #9: My Take</strong></p><p><strong>➡️ …continue reading on </strong><a href="https://www.fixhealth.ai/p/walmart-has-failed-at-healthcare"><strong>FixHealth.ai</strong></a></p><p>👉👉👉👉👉 Hi! My name is Sergei Polevikov. I’m an AI researcher and a healthcare AI startup founder. I combine my knowledge of AI models with my unique skills in analyzing the financial health of digital health companies, no pun intended. 😊 I never sugarcoat or filter the hard truth. Subscribe to my newsletter at <a href="https://fixhealth.ai/">FixHealth.ai</a>, follow me, support my work and join a vibrant community of healthcare AI enthusiasts! Your engagement matters. 🙏🙏🙏🙏🙏</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=073926fb0fcb" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Inside OpenEvidence, Part 2: Rented Model, Rented Content, $15B Price Tag]]></title>
            <link>https://medium.com/@AIHealthUncut/inside-openevidence-part-2-rented-model-rented-content-15b-price-tag-82caa6a489e1?source=rss-e2ea40a603da------2</link>
            <guid isPermaLink="false">https://medium.com/p/82caa6a489e1</guid>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[doximity]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[openevidence]]></category>
            <category><![CDATA[mergers-and-acquisitions]]></category>
            <dc:creator><![CDATA[Sergei Polevikov]]></dc:creator>
            <pubDate>Mon, 26 Oct 2026 19:27:30 GMT</pubDate>
            <atom:updated>2026-10-26T19:27:30.806Z</atom:updated>
            <content:encoded><![CDATA[<h3>Does OpenEvidence have a moat? No technical paper, no peer-reviewed study validating its own clinical accuracy, no proprietary content, and just 24% to 40% accuracy on real-world clinical questions.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*yb8QjmdOZyMrrR__UC6nAA.jpeg" /><figcaption>Photo of OpenEvidence CEO Daniel Nadler taken from a video of his July 15, 2026, interview at Goldman Sachs. Additional visual elements were added using Google Gemini.</figcaption></figure><p><strong><em>Welcome to AI Health Uncut, a brutally honest newsletter on AI, innovation, and the state of the healthcare market. If you’d like to sign up to receive issues over email, you can do so </em></strong><a href="https://www.fixhealth.ai/subscribe"><strong><em>here</em></strong></a><strong><em>.</em></strong></p><p><strong><em>Disclosure</em></strong><em>: I am an independent journalist. I have no financial position in OpenEvidence, Doximity, Teladoc, Waystar, Clarivate, Alphabet (Google), RELX (Elsevier), Wolters Kluwer, Wiley, Epic, Abridge, Hippocratic AI, Anthropic, OpenAI, Baseten, Nvidia, Databricks, Perplexity AI, Hugging Face, SpaceX, Oura, Peloton, Hinge Health, Omada Health, Hims &amp; Hers, Tempus AI, Veeva Systems, IDEXX Laboratories, Verily, Freenome, Commure, Atomic AI, Quadrivia AI, Heidi Health, K Health, UnitedHealth Group, Humana, Johnson &amp; Johnson, Pfizer, Merck, Biogen, Incyte, Goldman Sachs, S&amp;P Global, Softbank, FactSet, Evercore, Altaris, News Corp, The New York Times Company or any other company mentioned in this article or its charts. I have reached out to OpenEvidence and Daniel Nadler for comment multiple times and have received no response. The invitation to an interview on AI Health Uncut and on Digital Health Inside Out stands. Accounts attributed to people familiar with the company come from sources who spoke on condition of anonymity, and were verified against public records where possible. This article is my opinion, based on the sources cited, and is not investment, legal or medical advice.</em></p><p>In <a href="https://www.fixhealth.ai/p/inside-openevidence-the-art-of-selling">Part 1</a>, I looked at the economics of healthtech M&amp;A, with OpenEvidence as the case study: a company that claims $300M in ARR (annual recurring revenue), raised at a $15B valuation in September, and, <a href="https://www.businessinsider.com/chatgpt-for-medicine-openevidence-fielding-valuation-2026-9">per Business Insider</a>, “could be open to an M&amp;A deal” (M&amp;A: a merger or acquisition). By any comparable I can find, the business is worth ~$500M or less.</p><p>This Part 2 is about the technology. If a buyer pays $15B, what exactly are they buying? A proprietary AI? Proprietary content? Proven accuracy? I looked for all three.</p><p>Part 2 is also about the people: how OpenEvidence and its CEO treat critics, and what a buyer would really get in the team.</p><p>To everyone who helped with this piece: thank you. It’s because of people like you that I continue doing this work.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2Fetrn_PvITko%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fshorts%2Fetrn_PvITko&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2Fetrn_PvITko%2Fhq2.jpg&amp;type=text%2Fhtml&amp;schema=youtube" width="640" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/3675d476945b6bd289d98ac366ccce71/href">https://medium.com/media/3675d476945b6bd289d98ac366ccce71/href</a></iframe><p><em>A word about how this work gets paid for. Independent investigative journalism comes at a significant cost, both in time and legal risk. That’s why I have launched the </em><a href="https://www.fixhealth.ai/sponsor"><em>AI Health Uncut Sponsorship Program</em></a><em>. AI Health Uncut’s subscribers include prominent leaders in healthcare, technology and investment, including household names you would undoubtedly recognize. Sponsorship puts your work in front of all these people, who help shape the industry’s direction, its funding and its adoption of new technologies. Sponsorship does not buy favorable editorial coverage. But I welcome like-minded sponsors who respect my editorial independence and don’t interfere with what I write.</em></p><p><a href="https://fixhealth.ai/sponsor"><strong>Become a Sponsor of AI Health Uncut</strong></a></p><p><em>I also encourage my readers to become </em><a href="https://www.fixhealth.ai/subscribe?tier=founding"><em>Founding Members</em></a><em>. I need your support. By joining, you’re not only supporting my continued investigations and research into healthcare AI. You’re also helping me make this work accessible to people who may not be able to afford a subscription, whether they’re students, between jobs, or simply going through a difficult financial period. (If that’s you, please reach out.) Thanks to the generosity of Founding Members, I’m able to provide access to anyone who needs it. Your support is what keeps the lights on.</em></p><p><a href="https://www.fixhealth.ai/subscribe?tier=founding"><strong>Become a Founding Member</strong></a></p><p>Four things happened since Part 1:</p><ul><li><strong>The Doximity lawsuit is over.</strong> On October 16, the day after Part 1 ran, a federal judge in Massachusetts <a href="https://www.healthcaredive.com/news/openevidence-doximity-settle-explosive-ai-legal-battle/833480/">dismissed</a> OpenEvidence’s case against Doximity with prejudice. Each side pays its own legal fees, and the terms were not disclosed. Per Healthcare Dive, OpenEvidence was approaching a deadline to produce internal Slack messages that were allegedly deleted. Probably a coincidence. 😉 Either way, a pending federal lawsuit is exactly the kind of thing that spooks a buyer’s diligence team, and now there isn’t one.</li><li><strong>Another big-name announcement.</strong> On October 13, OpenEvidence and Johns Hopkins Medicine <a href="https://www.hopkinsmedicine.org/news/newsroom/news-releases/2026/10/openevidence-and-johns-hopkins-medicine-announce-landmark-collaboration-to-design-the-future-of-medicine-and-medical-education-in-the-age-of-ai">announced</a> a “landmark collaboration” on medical education and “human-first” AI for patient care. No financial terms, and no research or validation commitments. As I showed in Part 1, OpenEvidence’s announcements have a way of landing right before the money does.</li><li><strong>OpenEvidence got its first JAMA paper.</strong> On October 15, the day Part 1 ran, JAMA <a href="https://jamanetwork.com/journals/jama/article-abstract/2855491">published</a> a study of how clinicians use OpenEvidence: 271M queries from 952,008 clinicians, including 556,200 physicians, between January 2024 and June 2026. Three authors are tied to OpenEvidence, including its chief medical officer, and the company supplied the data. It is a usage study. It counts questions, not correct answers. More in section 5.</li><li><strong>The FT profile.</strong> On October 20, the Financial Times <a href="https://www.ft.com/content/0ed17b79-47dd-4ad8-8dca-44eb35617edc">ran</a> a mostly glowing profile. Per a person close to the company, OpenEvidence booked $100M in “ad buys” for 2025, a metric that includes future advertising commitments, and is on track for $400M to $500M from ads by the end of 2026. Neither number is audited. Even on that projection, $15B is 30x to 37.5x a single year of ad sales. Nadler called OpenEvidence “the first viral consumer internet app in healthcare” and said “the end game is literature-based drug discovery,” worth “orders of magnitude” more than “whatever we could have charged hospitals or advertisers.” So the ad business that supposedly justifies $15B is now the small part of the story.</li></ul><blockquote><strong><em>A note on how this works.</em></strong><em> Most of my investigations start with a tip from someone like you. I verify it with other witnesses, then add my own “mosaic theory” research on top. Everything stays confidential, always. I have been doing this for 3 years. What follows is a standing public service announcement that I run in every investigation. It is not directed at any company discussed in this piece, and nothing in this article alleges that OpenEvidence or any of its employees or representatives has broken the law or engaged in unethical conduct.</em></blockquote><blockquote><em>If you see something unethical, or even just weird, anywhere in healthtech, do not stay silent. Tell a newspaper, tell me (DMs, Signal, WhatsApp, whatever you prefer), or, if you believe a law has been broken, tell a law enforcement agency (</em><a href="https://tips.fbi.gov/"><em>tips.fbi.gov</em></a><em>).</em></blockquote><h3>Here is what’s inside:</h3><blockquote><strong><em>1. What’s Under the Hood (Still Undisclosed)</em></strong></blockquote><blockquote><strong><em>2. OpenEvidence Owns None of Its Content. Publishers Can Pull It at Any Time</em></strong></blockquote><blockquote><strong><em>3. OpenEvidence’s Accuracy: From 100% on the USMLE to 27% on Real-World Cases</em></strong></blockquote><blockquote><strong><em>4. The Nature Medicine Paper That Sparked OpenEvidence’s PR Meltdown</em></strong></blockquote><blockquote><strong><em>5. What the New Studies Say About OpenEvidence, and About RAG</em></strong></blockquote><blockquote><strong><em>6. Patients Not Allowed</em></strong></blockquote><blockquote><strong><em>7. How OpenEvidence and Its CEO Handle Critics</em></strong></blockquote><blockquote><strong><em>8. So, Does OpenEvidence Have a Moat?</em></strong></blockquote><p><strong>➡️ …continue reading on </strong><a href="https://www.fixhealth.ai/p/inside-openevidence-part-2-rented"><strong>FixHealth.ai</strong></a></p><p>👉👉👉👉👉 Hi! My name is Sergei Polevikov. I’m an AI researcher and a healthcare AI startup founder. I combine my knowledge of AI models with my unique skills in analyzing the financial health of digital health companies, no pun intended. 😊 I never sugarcoat or filter the hard truth. Subscribe to my newsletter at <a href="https://fixhealth.ai/">FixHealth.ai</a>, follow me, support my work and join a vibrant community of healthcare AI enthusiasts! Your engagement matters. 🙏🙏🙏🙏🙏</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=82caa6a489e1" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Inside OpenEvidence: The Art of Selling a $500M Company for $15B]]></title>
            <link>https://medium.com/@AIHealthUncut/inside-openevidence-the-art-of-selling-a-500m-company-for-15b-11fb0fb1269f?source=rss-e2ea40a603da------2</link>
            <guid isPermaLink="false">https://medium.com/p/11fb0fb1269f</guid>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[mergers-and-acquisitions]]></category>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[doximity]]></category>
            <category><![CDATA[openevidence]]></category>
            <dc:creator><![CDATA[Sergei Polevikov]]></dc:creator>
            <pubDate>Thu, 15 Oct 2026 13:20:14 GMT</pubDate>
            <atom:updated>2026-10-15T13:20:14.719Z</atom:updated>
            <content:encoded><![CDATA[<h3>People familiar with the company describe how CEO Daniel Nadler runs the company more like a hedge fund than a healthcare AI business.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*pyZJNaIiDx0e3NMKrMnqGw.png" /><figcaption>Photo of OpenEvidence CEO Daniel Nadler taken from a video of his July 15, 2026, interview at Goldman Sachs. Additional visual elements, including a money bag and a stethoscope, were added using Google Gemini.</figcaption></figure><p><strong><em>Disclosure</em></strong><em>: I am an independent journalist. I have no financial position in OpenEvidence, Doximity, Teladoc, Waystar, Clarivate, Alphabet (Google), RELX (Elsevier), Wolters Kluwer, Wiley, Epic, Abridge, Hippocratic AI, Anthropic, OpenAI, Baseten, Nvidia, Databricks, Perplexity AI, Hugging Face, SpaceX, Oura, Peloton, Hinge Health, Omada Health, Hims &amp; Hers, Tempus AI, Veeva Systems, IDEXX Laboratories, Verily, Freenome, Commure, Atomic AI, Quadrivia AI, Heidi Health, K Health, UnitedHealth Group, Humana, Johnson &amp; Johnson, Pfizer, Merck, Biogen, Incyte, Goldman Sachs, S&amp;P Global, FactSet, Evercore, Altaris or any other company mentioned in this article or its charts. I have reached out to OpenEvidence and Daniel Nadler for comment multiple times and have received no response. The invitation to an interview on AI Health Uncut and on Digital Health Inside Out stands. Accounts attributed to people familiar with the company come from sources who spoke on condition of anonymity, and were verified against public records where possible. This article is my opinion, based on the sources cited, and is not investment, legal or medical advice.</em></p><p>On September 24, Business Insider <a href="https://archive.is/5CPzn">reported</a> that OpenEvidence raised another $250M, this time from Andreessen Horowitz and a group of hospital systems, at a $15B valuation. Three paragraphs in, the real news: OpenEvidence “could be open to an M&amp;A deal that includes access to compute” (M&amp;A: a merger or acquisition).</p><blockquote><strong><em>Translation: the “ChatGPT for doctors” is for sale.</em></strong></blockquote><p><em>But first, a word about how this work gets paid for. Independent investigative journalism comes at a significant cost, both in time and legal risk, so I have launched the </em><a href="https://www.fixhealth.ai/sponsor"><em>AI Health Uncut Sponsorship Program</em></a><em>. AI Health Uncut’s subscribers include prominent leaders in healthcare, technology and investment, including household names you would undoubtedly recognize. Sponsorship puts your work in front of all these people, who help shape the industry’s direction, its funding and its adoption of new technologies. Sponsorship does not buy favorable editorial coverage. But I welcome like-minded sponsors who respect my editorial independence and don’t interfere with what I write.</em></p><p><a href="https://fixhealth.ai/sponsor"><strong><em>Become a Sponsor of AI Health Uncut</em></strong></a></p><p><em>I also encourage my readers to become </em><a href="https://www.fixhealth.ai/subscribe?tier=founding"><em>Founding Members</em></a><em>. I need your support. By joining, you’re not only supporting my continued investigations and research into healthcare AI. You’re also helping me make this work accessible to people who may not be able to afford a subscription, whether they’re students, between jobs, or simply going through a difficult financial period. (If that’s you, please reach out.) Thanks to the generosity of Founding Members, I’m able to provide access to anyone who needs it. Your support is what keeps the lights on.</em></p><p><a href="https://www.fixhealth.ai/subscribe?tier=founding"><strong><em>Become a Founding Member</em></strong></a></p><p>Now, back to OpenEvidence. The company claims $300M in ARR (annual recurring revenue), a self-reported number I will explain below. By any comparable I can find, the business is worth ~$500M or less. Nadler wants 30 times that. And given his Goldman Sachs pedigree and his investor list, he may just pull it off.</p><p>I have written about OpenEvidence <a href="https://www.fixhealth.ai/p/whats-actually-under-the-hood-of">many times</a>, and I still cannot tell you with certainty what the company is. Neither can anyone outside it. I reached out to OpenEvidence’s media department and to Daniel Nadler directly, more than once. No response. So I did what I always do: I talked to people closely familiar with the company, and I did a whole lot of my own research. What follows is based on confidential sources, court filings, the company’s own statements, and more than a year of my prior reporting.</p><p><strong>I name names. I hope you are sitting down.</strong></p><blockquote><strong><em>A note on how this works.</em></strong><em> Most of my investigations start with a tip from someone like you. I verify it with other witnesses, then add my own “mosaic theory” research on top. Everything stays confidential, always. I have been doing this for 3 years. What follows is a standing public service announcement that I run in every investigation. It is not directed at any company discussed in this piece, and nothing in this article alleges that OpenEvidence or any of its employees or representatives has broken the law or engaged in unethical conduct.</em></blockquote><blockquote><em>If you see something unethical, or even just weird, anywhere in healthtech, do not stay silent. Tell a newspaper, tell me (DMs, Signal, WhatsApp, whatever you prefer), or, if you believe a law has been broken, tell a law enforcement agency (</em><a href="https://tips.fbi.gov/"><em>tips.fbi.gov</em></a><em>).</em></blockquote><p>In this Part 1 of my investigation, I examine the economics of healthtech M&amp;A, using OpenEvidence as a case study.</p><p>In Part 2, coming next week, I’ll take a closer look at OpenEvidence’s technology and raise some serious questions about whether the company has a defensible competitive moat. Assuming, of course, I won’t be swimming with the fishes by then. 😉</p><h3>Here is what’s inside:</h3><p><strong><em>Part 1 (today):</em></strong></p><blockquote><strong><em>1. The $15B Ask and the $500M Reality</em></strong></blockquote><blockquote><strong><em>2. Livongo Is a Warning for OpenEvidence: An $18.5B Windfall for Founders and VCs, Followed by a $340M Reality Check</em></strong></blockquote><blockquote><strong><em>3. Can Nadler Pull Off a Livongo in the Most Expensive Sector of the Market?</em></strong></blockquote><blockquote><strong><em>4. Daniel Nadler Is a Wall Street Guy. So Was Ali Parsa</em></strong></blockquote><blockquote><strong><em>5. The Doximity Hires Lasted 10 to 14 Months</em></strong></blockquote><blockquote><strong><em>6. OpenEvidence vs. Doximity: The CEO’s Text Messages Are Next</em></strong></blockquote><blockquote><strong><em>7. What a Buyer Would Actually Be Buying from OpenEvidence</em></strong></blockquote><p><strong><em>Part 2 (coming next week):</em></strong></p><blockquote><strong><em>8. What’s Under the Hood (Still Undisclosed)</em></strong></blockquote><blockquote><strong><em>9. OpenEvidence Owns None of Its Content, and the Publishers Can Pull It</em></strong></blockquote><blockquote><strong><em>10. OpenEvidence’s Accuracy: From 100% on the USMLE to Just 27% on Real-World Cases</em></strong></blockquote><blockquote><strong><em>11. The Nature Medicine Paper That Sparked OpenEvidence’s PR Meltdown</em></strong></blockquote><blockquote><strong><em>12. What 3 New Papers Say About OpenEvidence, and About RAG</em></strong></blockquote><blockquote><strong><em>13. Patients Not Allowed</em></strong></blockquote><p><strong>➡️ …continue reading on </strong><a href="https://www.fixhealth.ai/p/inside-openevidence-the-art-of-selling"><strong>FixHealth.ai</strong></a></p><p>👉👉👉👉👉 Hi! My name is Sergei Polevikov. I’m an AI researcher and a healthcare AI startup founder. I combine my knowledge of AI models with my unique skills in analyzing the financial health of digital health companies, no pun intended. 😊 I never sugarcoat or filter the hard truth. Subscribe to my newsletter at <a href="https://fixhealth.ai/">FixHealth.ai</a>, follow me, support my work and join a vibrant community of healthcare AI enthusiasts! Your engagement matters. 🙏🙏🙏🙏🙏</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=11fb0fb1269f" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[WTF is going on at K Health?]]></title>
            <link>https://medium.com/@AIHealthUncut/wtf-is-going-on-at-k-health-13476221bb81?source=rss-e2ea40a603da------2</link>
            <guid isPermaLink="false">https://medium.com/p/13476221bb81</guid>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[healthk]]></category>
            <category><![CDATA[symptom-checkers]]></category>
            <category><![CDATA[ai-in-healthcare]]></category>
            <dc:creator><![CDATA[Sergei Polevikov]]></dc:creator>
            <pubDate>Thu, 08 Oct 2026 22:07:59 GMT</pubDate>
            <atom:updated>2026-10-08T22:07:59.059Z</atom:updated>
            <content:encoded><![CDATA[<h3>Allon Bloch took every hard question like a pro, and PatientGPT is real and growing. He still never said what model runs it, or why the symptom checker ranked 40 out of 40 died on Dec 31, 2025.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*OYQbqjb_5qYsALJGpEyTKw.png" /></figure><p><strong><em>Welcome to AI Health Uncut, a brutally honest newsletter on AI, innovation, and the state of the healthcare market. If you’d like to sign up to receive issues over email, you can do so </em></strong><a href="https://www.fixhealth.ai/subscribe"><strong><em>here</em></strong></a><strong><em>.</em></strong></p><p><strong><em>Disclosure.</em></strong><em> This publication is written and distributed by an independent journalist. It is protected by the First Amendment to the U.S. Constitution and related principles of free expression. Those protections do not relieve me of the obligation to report accurately, and I take that obligation seriously. I have no financial interest, long or short, in K Health, Hartford HealthCare, Cedars-Sinai, Atlantic Health, UVA Health, Mayo Clinic, Epic, Heidi, Abridge, OpenEvidence, Hippocratic AI, Commure, Ada Health, Infermedica, Doctorlink, OpenAI, or any other company mentioned here. Allon Bloch appeared on Digital Health Inside Out as an unpaid guest. K Health did not pay for, review, or approve this article. Quotes come from the recording of the October 1, 2026 interview, lightly cleaned up for readability. Facts come from the sources hyperlinked at the point of reference. This article is for informational and opinion purposes only and should not be construed as financial or investment advice.</em></p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FxBnb5TXtNig%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DxBnb5TXtNig&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FxBnb5TXtNig%2Fhqdefault.jpg&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/9fe2498f32baea60f327720c4b77c5a6/href">https://medium.com/media/9fe2498f32baea60f327720c4b77c5a6/href</a></iframe><p>On October 1, 2026, <a href="https://www.linkedin.com/in/alex-koshykov/">Alex Koshykov</a> and I interviewed <a href="https://www.linkedin.com/in/allon-bloch-70b1223/">Allon Bloch</a>, CEO and co-founder of K Health, on <a href="https://www.youtube.com/watch?v=xBnb5TXtNig">Digital Health Inside Out</a>. Allon knew the questions would be hard. He came anyway and was a good sport for all 70 minutes. He never answered my 2 biggest questions. He did answer plenty of others, and some of those answers were better than I expected. Watch this rather spicy episode <a href="https://www.youtube.com/watch?v=xBnb5TXtNig">here</a>.</p><h3>Here is what’s inside:</h3><blockquote><strong><em>1. How a “WTF” Tweet Turned Into an Interview</em></strong></blockquote><blockquote><strong><em>2. The Symptom Checker That Ranked 40 Out of 40</em></strong></blockquote><blockquote><strong><em>3. Where Allon and I Agree: Bayesian Trees, Medical Records and GLP-1s</em></strong></blockquote><blockquote><strong><em>4. What Runs PatientGPT? Nobody Knows</em></strong></blockquote><blockquote><strong><em>5. What PatientGPT Actually Does Well</em></strong></blockquote><blockquote><strong><em>6. Credit Where Credit Is Due</em></strong></blockquote><p><strong>➡️ …continue reading on </strong><a href="https://www.fixhealth.ai/p/wtf-is-going-on-at-k-health"><strong>FixHealth.ai</strong></a></p><p>👉👉👉👉👉 Hi! My name is Sergei Polevikov. I’m an AI researcher and a healthcare AI startup founder. I combine my knowledge of AI models with my unique skills in analyzing the financial health of digital health companies, no pun intended. 😊 I never sugarcoat or filter the hard truth. Subscribe to my newsletter at <a href="https://fixhealth.ai/">FixHealth.ai</a>, follow me, support my work and join a vibrant community of healthcare AI enthusiasts! Your engagement matters. 🙏🙏🙏🙏🙏</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=13476221bb81" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Nolla’s “Autonomous” AI Prescriber Still Needs a Doctor’s Signature]]></title>
            <link>https://medium.com/@AIHealthUncut/nollas-autonomous-ai-prescriber-still-needs-a-doctor-s-signature-bc2a559ac1e5?source=rss-e2ea40a603da------2</link>
            <guid isPermaLink="false">https://medium.com/p/bc2a559ac1e5</guid>
            <category><![CDATA[ai-prescribing]]></category>
            <category><![CDATA[fda]]></category>
            <category><![CDATA[ai-in-healthcare]]></category>
            <category><![CDATA[utah]]></category>
            <category><![CDATA[health-technology]]></category>
            <dc:creator><![CDATA[Sergei Polevikov]]></dc:creator>
            <pubDate>Tue, 06 Oct 2026 14:26:58 GMT</pubDate>
            <atom:updated>2026-10-06T14:26:58.138Z</atom:updated>
            <content:encoded><![CDATA[<h3>Utah’s 3rd AI prescribing pilot in 9 months. A 96% accuracy claim with no study. Scripts carrying a clinician’s name the clinician never wrote. And General Catalyst in the cap table. 🤦‍♂️</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*o_9OoEmRq-SUaLFdkiG2nA.png" /><figcaption>Note: This cover image was generated with Claude and does not depict an actual product, prescription, or state document.</figcaption></figure><p><strong><em>Important Disclosure.</em></strong><em> I am an independent journalist with no financial interest, long or short, in any company mentioned here, including Nolla Health, Doctronic, Legion Health, General Catalyst, HATCo, Summa Health, Commure, Hippocratic AI, Heidi Health, Livongo, Teladoc, Mindstrong, SonderMind, Olive AI, Hims &amp; Hers, OpenEvidence, SteadyMD, MDCalc, Mindgard, Aidoc, Clarium, Fabric, Judi Health, Transcarent and Verse Medical. Facts come from public records, company statements and press coverage, hyperlinked at the point of reference. Opinions are my own. Not investment advice.</em></p><p>Yesterday, <a href="https://www.bloomberg.com/news/articles/2026-10-05/nolla-health-ai-can-now-prescribe-acne-drugs-in-utah-without-doctors">Bloomberg reported</a> that Nolla Health, a New York startup born in Norway, became the first company allowed to let software write new prescriptions in the United States. Topical acne drugs only, Utah only, for 1 year with an option for 2 more. CEO Luis Wenus called it the “<a href="https://x.com/luiswenus">first ever actual end-to-end AI doctor</a>” in a post that drew almost 2M views. The approval came from the same Department of Commerce office that waved through <a href="https://www.fixhealth.ai/p/doctronic-the-ai-doctor-with-a-dirty">Doctronic’s AI refills</a> in January and Legion Health’s AI psychiatric refills in May. Nolla’s lead investor is General Catalyst, the firm that <a href="https://www.fixhealth.ai/p/general-catalysts-summa-bet-heads">bought a hospital</a> 12 months ago. God help us all. 🙏</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*BkAiy8a1Vsu8LUut.png" /><figcaption>Source: <a href="https://www.nollahealth.com/ai-prescriptions">https://www.nollahealth.com/ai-prescriptions</a></figcaption></figure><p>But first, I’m excited to be attending <a href="https://hlth.com/events/usa">HLTH USA 2026</a>, the marquee healthcare innovation event, November 15–18 in Las Vegas! Join me: <a href="https://app.ingo.me/q/56jqv">https://app.ingo.me/q/56jqv</a></p><p>🎙️ Calling all medical professionals, healthtech folks, and fans of our podcast, <a href="https://www.youtube.com/@DigitalHealthInsideOut">Digital Health Inside Out</a>. <a href="https://www.linkedin.com/in/alex-koshykov/">Alex Koshykov</a> and I are looking for a few brave souls willing to join us for in-person conversations that may range from serious healthcare debates to completely inappropriate healthtech dad jokes. 😄 We’ll be recording right from the floor of <a href="https://hlth.com/events/usa">HLTH in Las Vegas</a>, November 15–18. 🎰🔥 If you’ll be there and think you’d be a good sport, drop a comment or send either of us a DM. One thing we can promise. It won’t be boring. And yes, things may get a little heated from time to time. 😉</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*7ICpgk4lQ7-zA3Ec.jpeg" /></figure><p><em>Also, I encourage my readers to become Founding Members of my Substack. </em><strong><em>I need your support.</em></strong></p><p><em>By joining, you’re not only supporting my continued investigations and research into healthcare AI. You’re also helping me make this work accessible to people who may not be able to afford a subscription, whether they’re students, between jobs, or simply going through a difficult financial period. (If that’s you, please reach out.)</em></p><p><em>That’s precisely why I created the </em><a href="https://www.fixhealth.ai/subscribe?tier=founding"><em>AI Health Uncut Founding Member Club</em></a><em>. Thanks to the generosity of these wonderful individuals, I’m able to provide access to anyone who needs it.</em></p><p><a href="https://www.fixhealth.ai/subscribe?tier=founding"><strong>Become a Founding Member of My Substack</strong></a></p><h3>Here is what’s inside:</h3><blockquote><strong><em>1. “Autonomous,” With a Physician’s Signature</em></strong></blockquote><blockquote><strong><em>2. 3 AI Prescribers in 9 Months, All Approved by Commerce, Not Health</em></strong></blockquote><blockquote><strong><em>3. Doctronic Claimed 99.2%. Nolla Claims 96%. Based on What Evidence? 🤷</em></strong></blockquote><blockquote><strong><em>4. “Those Prices Are Nuts!” The $4.99 Headline Is Really $55 a Month</em></strong></blockquote><blockquote><strong><em>5. General Catalyst Is on Both Ends of the Prescription</em></strong></blockquote><blockquote><strong><em>6. What Would Make Me Sign Up</em></strong></blockquote><p><strong>➡️ …continue reading on </strong><a href="https://www.fixhealth.ai/p/nollas-autonomous-ai-prescriber-still"><strong>FixHealth.ai</strong></a></p><p>👉👉👉👉👉 Hi! My name is Sergei Polevikov. I’m an AI researcher and a healthcare AI startup founder. I combine my knowledge of AI models with my unique skills in analyzing the financial health of digital health companies, no pun intended. 😊 I never sugarcoat or filter the hard truth. Subscribe to my newsletter at <a href="https://fixhealth.ai/">FixHealth.ai</a>, follow me, support my work and join a vibrant community of healthcare AI enthusiasts! Your engagement matters. 🙏🙏🙏🙏🙏</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=bc2a559ac1e5" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Who Owns the Doctor in 2031: Epic or OpenAI?]]></title>
            <link>https://medium.com/@AIHealthUncut/who-owns-the-doctor-in-2031-epic-or-openai-33eaee137576?source=rss-e2ea40a603da------2</link>
            <guid isPermaLink="false">https://medium.com/p/33eaee137576</guid>
            <category><![CDATA[podcast]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[openai]]></category>
            <category><![CDATA[epic-systems]]></category>
            <category><![CDATA[oura-ring]]></category>
            <dc:creator><![CDATA[Sergei Polevikov]]></dc:creator>
            <pubDate>Fri, 02 Oct 2026 00:59:22 GMT</pubDate>
            <atom:updated>2026-10-02T00:59:22.644Z</atom:updated>
            <content:encoded><![CDATA[<h3>A banker came on Digital Health Vitals and bet against me. 😂 Plus: Oura pulls its IPO a day after we recorded, CommonSpirit’s $1.9B RCM divorce, and thumbs on Heidi, Tandem, Archy and Rightway.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*MMrGvh8wzCytyYUFPOL9eA.png" /></figure><p>Once again, it’s time for some seriously spicy healthtech news from September on the Digital Health Inside Out podcast, the Digital Health Vitals edition. 🌶️🔥</p><p>But first, I’m excited to be attending HLTH USA 2026, the marquee healthcare innovation event, November 15–18 in Las Vegas! Join me: <a href="https://app.ingo.me/q/56jqv">https://app.ingo.me/q/56jqv</a></p><p>🎙️ Calling all medical professionals, healthtech folks, and fans of our podcast, <a href="https://www.youtube.com/@DigitalHealthInsideOut">Digital Health Inside Out</a>. <a href="https://www.linkedin.com/in/alex-koshykov/">Alex Koshykov</a> and I are looking for a few brave souls willing to join us for in-person conversations that may range from serious healthcare debates to completely inappropriate healthtech dad jokes. 😄 We’ll be recording right from the floor of <a href="https://hlth.com/events/usa">HLTH in Las Vegas</a>, November 15–18. 🎰🔥 If you’ll be there and think you’d be a good sport, drop a comment or send either of us a DM. One thing we can promise. It won’t be boring. And yes, things may get a little heated from time to time. 😉</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*rmJQh_8MiIGCJEoQ.jpeg" /></figure><p>On Monday, Sep 28, <a href="https://www.linkedin.com/in/alex-koshykov/">Alex Koshykov</a> and I recorded the September <a href="https://www.youtube.com/@DigitalHealthInsideOut">Digital Health Vitals</a> with special guest <a href="https://www.hillcapitalcorp.com/">Patrick E. Donohue</a>, founder of Hill Capital Corporation, a former healthcare analyst and banker whose next fund is all health tech. Stephanie Davis had to skip this one.</p><p><a href="https://www.youtube.com/watch?v=jol-sWwOUYc">Watch the episode here.</a></p><p>And here is <a href="https://www.fixhealth.ai/p/health-catalyst-sold-its-profits">August’s recap.</a></p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2Fjol-sWwOUYc%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Djol-sWwOUYc&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2Fjol-sWwOUYc%2Fhqdefault.jpg&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/770681cee42056de46a7a9cb0ef201f0/href">https://medium.com/media/770681cee42056de46a7a9cb0ef201f0/href</a></iframe><h3>TL;DR</h3><ul><li>Oura postponed its $2.1B IPO on Tuesday, a day after we recorded. <a href="https://www.fixhealth.ai/p/oura-is-peloton-20-and-not-in-a-good">I called the 4x book weak</a> on air.</li><li><a href="https://www.fixhealth.ai/p/chatgpt-health-epic-integration-just">ChatGPT inside Epic</a> is a distribution event, not a technology event.</li><li><a href="https://www.fixhealth.ai/p/everyone-is-buying-rcm-commonspirit">CommonSpirit paid $1.9B to leave Conifer</a>, an RCM company. Patrick and I expect more insourcing.</li><li>Who owns the clinician AI layer in 5 years? I said Epic. Patrick said foundation models.</li><li>Thumbs: Heidi 3 up (mine with an asterisk), Tandem 2 up, Archy 3 up, Rightway split 3 ways.</li></ul><h3>Here is the episode outline:</h3><blockquote><strong><em>1. Oura: Recorded Monday, Postponed Tuesday</em></strong></blockquote><blockquote><strong><em>2. ChatGPT + Epic: Distribution, Not Technology</em></strong></blockquote><blockquote><strong><em>3. The 5-Year Bet: Epic or the Foundation Models</em></strong></blockquote><blockquote><strong><em>4. CommonSpirit Paid $1.9B to Get Rid of RCM</em></strong></blockquote><blockquote><strong><em>5. Thumbs 👍🏼, Thumbs 👎🏼: Heidi, Tandem, Archy, Rightway</em></strong></blockquote><p><strong>➡️ …continue reading on </strong><a href="https://www.fixhealth.ai/p/who-owns-the-doctor-in-2031-epic"><strong>FixHealth.ai</strong></a></p><p>👉👉👉👉👉 Hi! My name is Sergei Polevikov. I’m an AI researcher and a healthcare AI startup founder. I combine my knowledge of AI models with my unique skills in analyzing the financial health of digital health companies, no pun intended. 😊 I never sugarcoat or filter the hard truth. Subscribe to my newsletter at <a href="https://fixhealth.ai/">FixHealth.ai</a>, follow me, support my work and join a vibrant community of healthcare AI enthusiasts! Your engagement matters. 🙏🙏🙏🙏🙏</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=33eaee137576" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Oura Is Peloton 2.0, and Not in a Good Way]]></title>
            <link>https://medium.com/@AIHealthUncut/oura-is-peloton-2-0-and-not-in-a-good-way-65e3b7a4f6eb?source=rss-e2ea40a603da------2</link>
            <guid isPermaLink="false">https://medium.com/p/65e3b7a4f6eb</guid>
            <category><![CDATA[ipo]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[oura]]></category>
            <category><![CDATA[oura-ring]]></category>
            <category><![CDATA[wearables]]></category>
            <dc:creator><![CDATA[Sergei Polevikov]]></dc:creator>
            <pubDate>Tue, 29 Sep 2026 16:11:20 GMT</pubDate>
            <atom:updated>2026-09-29T16:11:20.807Z</atom:updated>
            <content:encoded><![CDATA[<h3>Oura delays its $2.1B IPO after a super weak 4x oversubscription. Same 80/20 hardware and subscription split as Peloton. Same “we’re a platform” pitch. But Oura would have kept just $6.2M. 🤦‍♂️</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*I4lV0AqYkvhNdFhnLiCnNQ.png" /></figure><p>It’s almost as if Tom Hale, Oura’s CEO, read my September 5 piece, “<a href="https://www.fixhealth.ai/p/oura-is-peloton-20-and-not-in-a-good">Oura IPO: Slick Gadget, Shaky Business</a>,” and decided not to test my thesis in public markets just yet. 😉</p><p>🚨 But first, an announcement.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/848/0*IsG70_EiG8sYt6AK.jpeg" /></figure><p>🎙️ Calling all medical professionals, healthtech folks, and fans of our podcast, <a href="https://www.youtube.com/@DigitalHealthInsideOut">Digital Health Inside Out</a>. <a href="https://www.linkedin.com/in/alex-koshykov/">Alex Koshykov</a> and I are looking for a few brave souls willing to join us for in-person conversations that may range from serious healthcare debates to completely inappropriate healthtech dad jokes. 😄 We’ll be recording right from the floor of <a href="https://hlth.com/events/usa">HLTH in Las Vegas</a>, November 15–18. 🎰🔥 If you’ll be there and think you’d be a good sport, drop a comment or send either of us a DM. One thing we can promise. It won’t be boring. And yes, things may get a little heated from time to time. 😉</p><p><em>By the way, if you cannot afford this article, perhaps you’re a student or currently between jobs, please reach out. That’s precisely why I created the </em><a href="https://www.fixhealth.ai/subscribe?tier=founding"><em>AI Health Uncut Founding Member Club</em></a><em> on Susbtack. Thanks to generous donations from these wonderful individuals, I’m able to provide access to anyone who needs it.</em></p><p><a href="https://www.fixhealth.ai/subscribe?tier=founding"><strong>Become a Founding Member of My Substack</strong></a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/399/0*R_kK8LF2HJK3BgfP" /><figcaption>Source: <a href="https://www.instagram.com/bloombergbusiness/?utm_source=ig_embed&amp;ig_rid=AEG9Tmtv3zgadfZB8LrXiSb">https://www.instagram.com/bloombergbusiness/?utm_source=ig_embed&amp;ig_rid=AEG9Tmtv3zgadfZB8LrXiSb</a></figcaption></figure><p>Oura <a href="https://www.cnbc.com/2026/09/29/smart-ring-maker-oura-postpones-ipo-due-to-market-uncertainty.html">postponed its IPO</a> this morning. It was <a href="https://finance.yahoo.com/markets/stocks/articles/oura-delays-us-ipo-adding-101545233.html">set to price tonight</a> and begin trading on Nasdaq as <a href="https://www.businesswire.com/news/home/20260920171761/en/URA-Announces-Launch-of-Initial-Public-Offering">OURA</a> tomorrow. In its <a href="https://www.businesswire.com/news/home/20260929159734/en/Oura-Postpones-Initial-Public-Offering">announcement</a>, Oura blamed “uncertainty in the IPO market,” despite “strong demand.” It <a href="https://www.fiercehealthcare.com/health-tech/smart-ring-maker-oura-postpones-public-listing-due-uncertainty-ipo-market">says</a> the business “has further strengthened since beginning the IPO process” and expects 5.7M paid members by the end of its fiscal year tomorrow. CEO Tom Hale said Oura has “the luxury of choosing our moment.” No new date was given.</p><p>Uh, OK… But we were not born yesterday.</p><p>Let’s get real. The demand was super weak. <a href="https://www.bloomberg.com/news/articles/2026-09-25/smart-ring-maker-oura-s-ipo-is-about-four-times-oversubscribed">Bloomberg reported</a> the IPO shares book was only ~4x oversubscribed (boooo 👎). <a href="https://www.ksl.com/article/51626569/smart-ring-maker-oura-shareholders-look-to-raise-up-to-22-billion-in-us-ipo">Eli Lilly and Dragoneer</a> had indicated interest in up to $400M of stock between them. As I show in Section 10, 4x is very weak for a deal this size.</p><p>On September 5, I read Oura’s <a href="https://www.sec.gov/Archives/edgar/data/2133022/000119312526381855/d119865ds1.htm">S-1</a> and called it <a href="https://www.fixhealth.ai/p/oura-ipo-slick-gadget-shaky-business">Slick Gadget, Shaky Business</a>. I also put a three-part prediction on record. Tonight was supposed to test the first part. The <a href="https://www.sec.gov/Archives/edgar/data/2133022/000119312526396051/d119865ds1a.htm">amended filing</a> from September 21 answered the question the first one left open: <strong>who receives the IPO money</strong>. The postponement raises a new question:</p><blockquote><strong><em>Who loses when the IPO waits?</em></strong><em> Mostly Oura employees who were planning to buy a new house or finally retire, but now find their RSUs stuck on ice.</em></blockquote><p>The filing also reminded me of another company. In September 2019, a connected-hardware brand with triple-digit growth, a subscription story, and a devoted early customer base <a href="https://en.wikipedia.org/wiki/Peloton_Interactive">went public at $8.1B</a>. It was Peloton.</p><h3>🚨 TL;DR:</h3><ul><li>Oura <a href="https://www.cnbc.com/2026/09/29/smart-ring-maker-oura-postpones-ipo-due-to-market-uncertainty.html">postponed its IPO</a> on the day it was set to price, blaming “uncertainty in the IPO market.” Its subscription book was only ~4x covered.</li><li>Subscriptions were 19.8% of Peloton’s revenue in its IPO year. Subscriptions are 19.8% of Oura’s today, and that share has little room to grow.</li><li>Peloton grew 110% the year it listed. Revenue has fallen every year since its fiscal 2021 peak, and its market value is down 96%.</li><li>Both learned that hardware breaks. Peloton had recalls. Oura booked $84.4M of Ring 4 warranty expense in a year it earned $12,000.</li><li>Oura is profitable. Peloton was not. But Oura’s 85% retention trails Peloton’s 95%, and I doubt even 85% will hold.</li><li>Three VCs were set to sell 73% of the IPO shares, Forerunner its entire stake. After employee RSU taxes, Oura would have kept just $6.2M.</li><li>Only 3 of 123 US IPOs since 2019 spent nearly all their proceeds on RSU taxes. None paired it with as much insider selling as Oura planned.</li><li>At the IPO midpoint, Oura would have been worth ~<strong>2443x</strong> its 2015 seed valuation and ~<strong>20.5x</strong> Forerunner’s 2020 round. Three early VCs were heading for the exit. In my view, that was a horrible signal. Private rounds are easy to inflate. Millions of public shareholders are harder to fool.</li><li>A 4x book is weak. The typical large US IPO since 2023 drew 20x. Only Reddit and SpaceX, which raised $86B, came close to Oura’s 4x. Waiting costs Oura little. Its employees pay the price, with RSUs stuck on ice. So do the selling VCs, with ~$1.53B of sales on hold.</li><li>At ~10x to 11x revenue, Oura’s IPO range was stretched, but not crazy. Peloton listed at ~9x.</li><li>On the IPO plan, Oura looks more like Fitbit, which popped 48% on day one and sold to Google 4 years later, 63% below its IPO price.</li><li>Oura’s “predictive health” looks like an unrealized vision from good people, not deception. But the IPO was priced on the vision.</li><li>Peloton had Covid. Oura has AI. My September 5 prediction is on hold with the IPO, but I’m standing by it, Finnish jewelry and all. 😉</li></ul><h3>Here is what’s inside:</h3><blockquote><strong><em>1. Oura vs. Peloton: Same 80/20 Revenue Split, Same Platform Pitch</em></strong></blockquote><blockquote><strong><em>2. Peloton’s Growth Stalled Once the Tech Enthusiasts Had Bought</em></strong></blockquote><blockquote><strong><em>3. Both Learned That Hardware Breaks</em></strong></blockquote><blockquote><strong><em>4. Where Oura Is Not Peloton</em></strong></blockquote><blockquote><strong><em>5. Peloton (and Fitbit) Raised IPO Money to Fund Growth. Oura Planned to Spend It All on Day 1.</em></strong></blockquote><blockquote><strong><em>6. A Primer on Why Oura Pays the RSU Tax Bill, Not Its Employees</em></strong></blockquote><blockquote><strong><em>7. How Rare It Is to Spend an IPO on Employee Taxes</em></strong></blockquote><blockquote><strong><em>8. Who Planned to Dump Oura Shares, and What They Sold Before</em></strong></blockquote><blockquote><strong><em>9. The VC Pump and Dump: Easy in Private Rounds, Harder in Public</em></strong></blockquote><blockquote><strong><em>10. Honestly, 4x Oversubscribed Is Weak. That’s Why Oura Postponed.</em></strong></blockquote><blockquote><strong><em>11. The Oura Revenue Multiple: Stretched, but Not Crazy</em></strong></blockquote><blockquote><strong><em>12. Google Paid $2.1B for Fitbit. Oura Wanted $14.9B on the Same Revenue.</em></strong></blockquote><blockquote><strong><em>13. Oura’s Predictive Promise: Ambitious, Not Deceptive</em></strong></blockquote><blockquote><strong><em>14. My Verdict, and My On-Record Prediction</em></strong></blockquote><p><strong>➡️ …continue reading on </strong><a href="https://www.fixhealth.ai/p/oura-is-peloton-20-and-not-in-a-good"><strong>FixHealth.ai</strong></a></p><p>👉👉👉👉👉 Hi! My name is Sergei Polevikov. I’m an AI researcher and a healthcare AI startup founder. I combine my knowledge of AI models with my unique skills in analyzing the financial health of digital health companies, no pun intended. 😊 I never sugarcoat or filter the hard truth. Subscribe to my newsletter at <a href="https://fixhealth.ai/">FixHealth.ai</a>, follow me, support my work and join a vibrant community of healthcare AI enthusiasts! Your engagement matters. 🙏🙏🙏🙏🙏</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=65e3b7a4f6eb" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[AI 0: Cancer 1]]></title>
            <link>https://medium.com/@AIHealthUncut/ai-0-cancer-1-2d916cc241cf?source=rss-e2ea40a603da------2</link>
            <guid isPermaLink="false">https://medium.com/p/2d916cc241cf</guid>
            <category><![CDATA[ai-drug-discovery]]></category>
            <category><![CDATA[cancer]]></category>
            <category><![CDATA[fda]]></category>
            <category><![CDATA[cancerbench]]></category>
            <category><![CDATA[cancer-treatments]]></category>
            <dc:creator><![CDATA[Sergei Polevikov]]></dc:creator>
            <pubDate>Fri, 25 Sep 2026 02:23:46 GMT</pubDate>
            <atom:updated>2026-09-25T02:23:46.117Z</atom:updated>
            <content:encoded><![CDATA[<h3>Five frontier models. Zero cancers cured. AI fixed Phase 1. Phase 2 and 3, the human trials, have not moved, and the FDA has no pathway for generative AI.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*4URvsFIb1irDV1ywy5Vw7w.png" /></figure><p>🚨 But first, a quick personal note…</p><p>Last week I spoke at the inaugural <a href="https://www.origin-point.health/">Origin Point</a> conference in La Jolla, and I’ll be as candid about it as I am about everything else: it was superb. About 85 people, lots of investors, lots of founders, and small enough that you could have real conversations instead of collecting badges. We covered everything from longevity, GLP-1s, peptides and biomarkers to consumer healthcare AI, wearables, AI agents, women’s health, M&amp;A, and, fittingly for this issue, AI’s potential role in curing cancer. Thank you to the organizers, <a href="https://open.substack.com/users/193453323-noah-voreades?utm_source=mentions">Noah Voreades</a>, Callie Baker and <a href="https://open.substack.com/users/350240686-jacqueline-jacques?utm_source=mentions">Jacqueline Jacques</a>, and to our panel moderator Julia Croxen and my fellow panelists <a href="https://open.substack.com/users/7445548-arpan-parikh-md-mba-fapa?utm_source=mentions">Arpan Parikh, MD MBA FAPA</a> and Anson Whitmer for a lively discussion on digital health, consumer health and AI products. Also, black caviar for breakfast. 😉 I posted more <a href="https://lnkd.in/p/eQSTVdSn">on LinkedIn</a>. If you get the chance to attend next year, definitely do it.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*lgggyRxeebyfU0B7.jpeg" /></figure><p><em>By the way, if you cannot afford this article, perhaps you’re a student or currently between jobs, please reach out. That’s precisely why I created the </em><a href="https://www.fixhealth.ai/subscribe?tier=founding"><em>AI Health Uncut Founding Member Club</em></a><em> on my Substack. Thanks to generous donations from these wonderful individuals, I’m able to provide access to anyone who needs it.</em></p><p><a href="https://www.fixhealth.ai/subscribe?tier=founding"><strong>Become a Founding Member of My Substack</strong></a></p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FNvoOTtpi0Bk%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DNvoOTtpi0Bk&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FNvoOTtpi0Bk%2Fhqdefault.jpg&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/57d59fd3f0cd9e7ba8bddb5c11f0e650/href">https://medium.com/media/57d59fd3f0cd9e7ba8bddb5c11f0e650/href</a></iframe><p>On September 6, Jensen Huang <a href="https://x.com/JensenHuang/status/2096700264569090384">posted</a> that OpenAI’s new GPT-6 Astra means “AGI has arrived.” Three days later, <a href="https://open.substack.com/users/388148397-tanishq-mathew-abraham?utm_source=mentions">Tanishq Mathew Abraham</a> <a href="https://cancerbench.com/">launched CancerBench</a>, a leaderboard with one metric: how many types of cancer has your frontier model cured? GPT-6 Astra scored 0. So did Claude Fable 5.1, Gemini 3.8 Flash, Grok 4.6, and Muse Spark 1.3. “All tied for first. And last.”</p><blockquote><strong><em>Is it AGI if it scored exactly zero on CancerBench? 🤔</em></strong></blockquote><p>On September 7 I published <a href="https://www.fixhealth.ai/p/there-is-no-money-in-ai-drug-discovery">There Is No Money in AI Drug Discovery</a>. The most common follow-up question was about cancer. This is the answer.</p><h3>TL;DR</h3><ul><li>CancerBench: 5 frontier models, 0 cancers cured, days after Nvidia’s CEO declared AGI. The <a href="https://time.com/article/2026/09/05/we-need-a-cure-for-ai-health-hype/">promises behind the joke</a> were serious: Amodei’s “~5–10 years,” Hassabis’s “next decade,” Altman’s “[choice] to cure cancer.”</li><li>AI-discovered molecules clear Phase 1 at 87.5% (21 of 24), against 52.0% historically. In Phase 2 they clear at 40% (4 of 10), no better than anyone else. None has finished a Phase 3. For cancer, the AI-specific Phase 2 record is 0 trials.</li><li>Oncology, the largest field in drug development, has among the worst odds: a 5.3% chance of approval from Phase 1, against 7.9% for all drugs, and a 24.6% Phase 2 pass rate, its worst phase.</li><li>Mayo Clinic’s AI-designed pancreatic cancer drug, GIPCi, is real, preclinical, and not yet in Phase 1. From there, the average oncology clock to approval is 10.3 years.</li><li>Human trials cannot be simulated, and the FDA has cleared exactly 0 generative AI products and has no pathway for one. My estimate: 10 to 20 years, not 5, and probably not with transformer AI.</li><li>Yesterday, on September 23, an FDA panel voted 6 to 4 that GRAIL’s machine-learning blood test <strong>Galleri</strong> is effective. It finds 13.6% of stage I cancers and 60% of stage IV. That is the AI-and-cancer frontier right now: a detection test, on a split vote.</li><li>Why the molecule keeps winning and the patient keeps losing. A 50-year cardiologist’s essay in The Pharos, and the FDA’s own record on cancer drugs approved on proxies: of 36 approved 2008 to 2012, 5 later proved to extend life. AI optimizes the part. The trial judges the whole.</li></ul><h3>Here is what’s inside:</h3><blockquote><strong><em>1. Five Frontier Models. Zero Cancers Cured.</em></strong></blockquote><blockquote><strong><em>2. AI Fixed Phase 1. Phase 2 and 3 Have Not Moved.</em></strong></blockquote><blockquote><strong><em>3. Mayo Clinic’s AI Cancer Drug Is Real. It Is Also Preclinical.</em></strong></blockquote><blockquote><strong><em>4. Human Trials Cannot Be Simulated, and the FDA Is Not Ready to Try</em></strong></blockquote><blockquote><strong><em>5. The FDA Panel Just Voted on an AI Cancer Test. It Was 6 to 4.</em></strong></blockquote><blockquote><strong><em>6. A Cardiologist’s Answer to Why the Molecule Wins and the Patient Loses</em></strong></blockquote><blockquote><strong><em>7. The Potemkin Dashboard and the Naked Emperors</em></strong></blockquote><blockquote><strong><em>8. Expect 10 to 20 Years, Not 5</em></strong></blockquote><p><strong>➡️ …continue reading on </strong><a href="https://www.fixhealth.ai/p/ai-0-cancer-1"><strong>FixHealth.ai</strong></a></p><p>👉👉👉👉👉 Hi! My name is Sergei Polevikov. I’m an AI researcher and a healthcare AI startup founder. I combine my knowledge of AI models with my unique skills in analyzing the financial health of digital health companies, no pun intended. 😊 I never sugarcoat or filter the hard truth. Subscribe to my newsletter at <a href="https://fixhealth.ai/">FixHealth.ai</a>, follow me, support my work and join a vibrant community of healthcare AI enthusiasts! Your engagement matters. 🙏🙏🙏🙏🙏</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=2d916cc241cf" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Why NASA Scientists Don’t Give a Sh*t About OpenAI Solving a Millennium Problem]]></title>
            <link>https://medium.com/@AIHealthUncut/why-nasa-scientists-dont-give-a-sh-t-about-openai-solving-a-millennium-problem-4a6a207bcbbc?source=rss-e2ea40a603da------2</link>
            <guid isPermaLink="false">https://medium.com/p/4a6a207bcbbc</guid>
            <category><![CDATA[nasa]]></category>
            <category><![CDATA[millennium-prize]]></category>
            <category><![CDATA[navier-stokes-equations]]></category>
            <category><![CDATA[openai]]></category>
            <category><![CDATA[fluid-dynamics]]></category>
            <dc:creator><![CDATA[Sergei Polevikov]]></dc:creator>
            <pubDate>Mon, 14 Sep 2026 20:12:16 GMT</pubDate>
            <atom:updated>2026-09-14T20:12:16.008Z</atom:updated>
            <content:encoded><![CDATA[<h3>This is what happens when coders mistake being good at solving riddles for being good in physics: confidence goes up, expertise stays put, and the exaggeration begins.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*KBfsDqEHnlUfxQ7al75a-w.png" /></figure><p><em>Apologies to my regular readers, but I ought to respond to a lot of nonsense circulating on the Internet right now about the Navier-Stokes Millennium Prize Problem. Unfortunately, a good deal of that nonsense is coming from OpenAI itself. I want to set the record straight. Apologies in advance for getting technical at times, but there is really no other way to address an issue this important.</em></p><p>What do a NASA scientist, an oil engineer, and a meteorologist all have in common? None of them gives a sh*t about <a href="https://openai.com/index/navier-stokes-solution/">OpenAI’s Navier-Stokes announcement</a>, even though all three run the Navier-Stokes equations in their models every single day.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2Fno_rm-e-NBU%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Dno_rm-e-NBU&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2Fno_rm-e-NBU%2Fhqdefault.jpg&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/e2d23ac5b0ddfe8a7644015ab4fe3905/href">https://medium.com/media/e2d23ac5b0ddfe8a7644015ab4fe3905/href</a></iframe><h3>TL;DR:</h3><ul><li>On Sep 8, 2026, OpenAI <a href="https://openai.com/index/navier-stokes-solution/">claimed</a> that roughly 10,000 AI agents <a href="https://www.quantamagazine.org/ai-has-solved-one-of-maths-1-million-millennium-prize-problems-20260908/">proved</a> the 3D Navier-Stokes equations can reach infinite velocity in finite time. OpenAI <a href="https://thenextweb.com/news/openai-navier-stokes-proof-published-millennium-prize">won’t claim the $1M prize</a>, the Clay Institute <a href="https://www.implicator.ai/clay-institute-navier-stokes-openai-proof-claim/">still lists the problem as open</a>, and 25 Fields medalists signed a <a href="https://terrytao.wordpress.com/2026/09/11/a-severe-misalignment-of-ai-in-mathematics/">declaration</a> on the “severe misalignment” of AI in mathematics.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*HXg0oeiKujp4lK0z.png" /><figcaption>Source: <a href="https://openai.com/index/navier-stokes-solution/">https://openai.com/index/navier-stokes-solution/</a></figcaption></figure><ul><li>Assume, for the moment, the proof actually holds. For NASA, aircraft makers, pipeline operators, and weather models, the near-term impact rounds to 0. Not 1 practitioner announced a model change. <a href="https://mathstodon.xyz/@tao/117207849921390904">Fields Medal winner Dr. Terence Tao</a> said as much five days before the announcement: a blow-up “would not radically transform” how we model weather or climate.</li><li>Engineers never solved Navier-Stokes analytically. They approximate it numerically, validate against wind tunnels and flight data, and have handled its instabilities for decades. Those calculations already work.</li><li>The practical problem was solved decades before the mathematical one.</li></ul><h3>Here is what’s inside:</h3><blockquote><strong><em>1. Everyone Is a Navier-Stokes Expert This Week</em></strong></blockquote><blockquote><strong><em>2. The Navier-Stokes Equation, in Plain English</em></strong></blockquote><blockquote><strong><em>3. Briefly on the Soap Opera, Then Let’s Move On</em></strong></blockquote><blockquote><strong><em>4. What NASA Actually Does With Navier-Stokes</em></strong></blockquote><blockquote><strong><em>5. Imagine NASA Simulating a Capsule at Mach 20</em></strong></blockquote><blockquote><strong><em>6. We Knew About the Swirls All Along</em></strong></blockquote><blockquote><strong><em>7. A 6th Reason Your Simulation Blew Up</em></strong></blockquote><blockquote><strong><em>8. Oil Pipelines and Weather</em></strong></blockquote><blockquote><strong><em>9. The Rockets Flew First. The Proof Came Later.</em></strong></blockquote><p><strong>➡️ …continue reading on </strong><a href="https://www.fixhealth.ai/p/why-nasa-scientists-dont-give-a-sht"><strong>FixHealth.ai</strong></a></p><p>👉👉👉👉👉 Hi! My name is Sergei Polevikov. I’m an AI researcher and a healthcare AI startup founder. I combine my knowledge of AI models with my unique skills in analyzing the financial health of digital health companies, no pun intended. 😊 I never sugarcoat or filter the hard truth. Subscribe to my newsletter at <a href="https://fixhealth.ai/">FixHealth.ai</a>, follow me, support my work and join a vibrant community of healthcare AI enthusiasts! Your engagement matters. 🙏🙏🙏🙏🙏</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=4a6a207bcbbc" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>